NAVAMEDIC (NAVA.OL) Stock Cash Flow
Europe - Euronext Oslo - OSL:NAVA - NO0010205966 - Common Stock
21.7 NOK
-0.3 (-1.36%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | N/A | -1.62M | 10.83M | 42.51M | 2.36M | |||
| Depreciation Amortization | N/A | 40.34M | 11.93M | 7.24M | 6.72M | |||
| Change In Working Capital | -28.07M | -3.36M | -33.24M | -31.00M | -16.70M | |||
| Interest Paid | N/A | 7.78M | 7.23M | 3.27M | 1.47M | |||
| Taxes Paid | N/A | 3.12M | 5.13M | 10.97M | 2.70M | |||
| Other non cash items | N/A | 4.00M | 12.66M | -808.00K | 6.32M | |||
| OPERATING CASH FLOW | 14.65M | 39.35M | 2.18M | 17.94M | -1.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -3.33M | -2.20M | -2.25M | -730.00K | |||
| Other Investing Activity | -185.58M | 547.00K | -102.39M | -23.19M | 0.00 | |||
| INVESTING CASH FLOW | -188.91M | -2.78M | -104.58M | -25.44M | -730.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -35.85M | 88.20M | 12.15M | 17.40M | |||
| Stock Issued/Repurchased | N/A | 5.89M | 2.26M | 1.20M | 0.00 | |||
| Other Financing Activity | 201.72M | -7.78M | -7.23M | -3.27M | -1.47M | |||
| FINANCING CASH FLOW | 171.76M | -37.74M | 83.23M | 10.07M | 15.93M | |||
| Exchange Rate Effect | 7.74M | 412.00K | 1.91M | 105.00K | -870.00K | |||
| CHANGE IN CASH | 5.25M | -751.00K | -17.26M | 2.68M | 13.03M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 14.65M | 39.35M | 2.18M | 17.94M | -1.30M | |||
| Capital Expenditure | N/A | -3.33M | -2.20M | -2.25M | -730.00K | |||
| FREE CASH FLOW | 11.33M | 36.03M | -19.00K | 15.69M | -2.03M | |||
All data in NOK